The development of novel vaginal microbicides: from the bench to the clinic.
- 1 February 2001
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15, S35-S37
- https://doi.org/10.1097/00002030-200102001-00052
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive womenSexually Transmitted Infections, 2000
- Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cellsBritish Journal of Pharmacology, 1994
- HIV Replication in CD4-Negative Cell Lines: Effect of Cloning, CD4 Expression and Inhibition by Dextrin SulphateAntiviral Chemistry and Chemotherapy, 1993
- Investigations into the Mechanism by Which Sulfated Polysaccharides Inhibit HIV Infection In VitroAIDS Research and Human Retroviruses, 1992
- Dextran Sulfate Suppression of Viruses in the HIV Family: Inhibition of Virion Binding to CD4 + CellsScience, 1988